Hepatitis B or hepatitis C and human immunodeficiency virus infection

Journal of Hepatology

Volumn 42, Issue SUPPL. 1, 2005, Pages

  Thimme, Robert ^a   Spangenberg, Hans Christian ^a   Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; HEPATITIS B VACCINE; LAMIVUDINE; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; COMORBIDITY; CONSENSUS DEVELOPMENT; DISEASE COURSE; DRUG CYTOTOXICITY; DRUG TOLERABILITY; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; LIVER GRAFT; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SCREENING TEST; VIRUS GENE; VIRUS REPLICATION;

EID: 14944377363     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.01.002     Document Type: Review

References (85)

1. H.E. Blum, and P. Marcellin EASL consensus conference on hepatitis B J Hepatol 2003 39
2. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52
3. A.S. Lok, E.J. Heathcote, and J.H. Hoofnagle Management of hepatitis B: 2000 - summary of a workshop Gastroenterology 120 2001 1828 1853
4. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update of recommendations Hepatology 39 2004 857 861
5. T. Poynard, M.F. Yuen, V. Ratziu, and C.L. Lai Viral hepatitis C Lancet 362 2003 2095 2100
6. D.B. Strader, T. Wright, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C Hepatology 39 2004 1147 1171
7. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002). Gastroenterology 2002;123:2082-2099.
8. D. Ganem, and A.M. Prince Hepatitis B virus infection - natural history and clinical consequences N Engl J Med 350 2004 1118 1129
9. F.J. Mahoney Update on diagnosis, management, and prevention of hepatitis B virus infection Clin Microbiol Rev 12 1999 351 366
10. C. Homann, K. Krogsgaard, C. Pedersen, P. Andersson, and J.O. Nielsen High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection J Acquir Immune Defic Syndr 4 1991 416 420
11. V.K. Rustgi, J.H. Hoofnagle, J.L. Gerin, E.P. Gelmann, C.M. Reichert, and J.N. Cooper Hepatitis B virus infection in the acquired immunodeficiency syndrome Ann Intern Med 101 1984 795 797
12. N.J. Bodsworth, D.A. Cooper, and B. Donovan The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state J Infect Dis 163 1991 1138 1140
13. R.J. Gilson, A.E. Hawkins, M.R. Beecham, E. Ross, J. Waite, and M. Briggs Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection Aids 11 1997 597 606
14. J.F. Colin, D. Cazals-Hatem, M.A. Loriot, M. Martinot-Peignoux, B.N. Pham, and A. Auperin Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men Hepatology 29 1999 1306 1310
15. C.L. Thio Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment Semin Liver Dis 23 2003 125 136
16. Y. Benhamou, M. Bochet, V. Di Martino, F. Charlotte, F. Azria, and A. Coutellier Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group Hepatology 30 1999 1054 1058
17. C.L. Thio, E.C. Seaberg, R. Skolasky Jr, J. Phair, B. Visscher, and A. Munoz HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS) Lancet 360 2002 1921 1926
18. D. Rey, V. Krantz, M. Partisani, M.P. Schmitt, P. Meyer, and E. Libbrecht Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load Vaccine 18 2000 1161 1165
19. I.P. Keet, G. van Doornum, A. Safary, and R.A. Coutinho Insufficient response to hepatitis B vaccination in HIV-positive homosexual men Aids 6 1992 509 510
20. A.S. Lok, and B.J. McMahon Chronic hepatitis B Hepatology 34 2001 1225 1241
21. M.G. Brook, P. Karayiannis, and H.C. Thomas Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors Hepatology 10 1989 761 763
22. R.P. Perrillo, and A.L. Mason Therapy for hepatitis B virus infection Gastroenterol Clin North Am 23 1994 581 601
23. D.K. Wong, C. Yim, C.D. Naylor, E. Chen, M. Sherman, and S. Vas Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population Gastroenterology 108 1995 165 171
24. G. Visco, L. Alba, S. Grisetti, P. Guarascio, P. Narciso, and P. Sette Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis Gut 34 1993 S107 S108
25. V. Di Martino, P. Rufat, N. Boyer, P. Renard, F. Degos, and M. Martinot-Peignoux The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study Hepatology 34 2001 1193 1199
26. V. Di Martino, T. Thevenot, J.F. Colin, N. Boyer, M. Martinot, and F. Degos Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B Gastroenterology 123 2002 1812 1822
27. Y. Benhamou, C. Katlama, F. Lunel, A. Coutellier, E. Dohin, and N. Hamm Effects of lamivudine on replication of hepatitis B virus in HIV-infected men Ann Intern Med 125 1996 705 712
28. G.J. Dore, D.A. Cooper, C. Barrett, L.E. Goh, B. Thakrar, and M. Atkins Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee J Infect Dis 180 1999 607 613
29. S.G. Lim, C.T. Wai, A. Rajnakova, T. Kajiji, and R. Guan Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B Gut 51 2002 597 599
30. Y. Benhamou, V. Di Martino, M. Bochet, G. Colombet, V. Thibault, and A. Liou Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy Hepatology 34 2001 283 287
31. B. Werle, K. Cinquin, P. Marcellin, S. Pol, M. Maynard, and C. Trepo Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy J Viral Hepat 11 2004 74 83
32. C.L. Thio Management of chronic hepatitis B in the HIV-infected patient AIDS Read 14 2004 122 129 see also p. 133, 127-136
33. M.B. Ristig, J. Crippin, J.A. Aberg, W.G. Powderly, M. Lisker-Melman, and L. Kessels Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed J Infect Dis 186 2002 1844 1847 Epub 2002 Nov 1822
34. M. Nelson, S. Portsmouth, J. Stebbing, M. Atkins, A. Barr, and G. Matthews An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals Aids 17 2003 F7 F10
35. F. van Bommel, T. Wunsche, S. Mauss, P. Reinke, A. Bergk, and D. Schurmann Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection Hepatology 40 2004 1421 1425
36. Y. Benhamou, and T. Poynard Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus J Hepatol 39 2003 S194 S199
37. M.E. Roland, and P.G. Stock Review of solid-organ transplantation in HIV-infected patients Transplantation 75 2003 425 429
38. M.J. Alter, H.S. Margolis, K. Krawczynski, F.N. Judson, A. Mares, and W.J. Alexander The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team N Engl J Med 327 1992 1899 1905
39. M.J. Alter, D. Kruszon-Moran, O.V. Nainan, G.M. McQuillan, F. Gao, and L.A. Moyer The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562
40. K.E. Sherman, S.D. Rouster, R.T. Chung, and N. Rajicic Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group Clin Infect Dis 34 2002 831 837 Epub 2002 Feb 2006
41. F. Saillour, F. Dabis, M. Dupon, D. Lacoste, P. Trimoulet, and P. Rispal Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine Br Med J 313 1996 461 464
42. D.M. Gibb, R.L. Goodall, D.T. Dunn, M. Healy, P. Neave, and M. Cafferkey Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission Lancet 356 2000 904 907
43. F.J. Palella Jr, K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, and G.A. Satten Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 1998 853 860
44. M.S. Sulkowski, E.E. Mast, L.B. Seeff, and D.L. Thomas Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus Clin Infect Dis 30 2000 S77 S84
45. D.L. Thomas, J. Astemborski, R.M. Rai, F.A. Anania, M. Schaeffer, and N. Galai The natural history of hepatitis C virus infection: host, viral, and environmental factors J Am Med Assoc 284 2000 450 456
46. B.A. Piasecki, J.D. Lewis, K.R. Reddy, S.L. Bellamy, S.B. Porter, and R.M. Weinrieb Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population Hepatology 40 2004 892 899
47. H.K. Monga, M.C. Rodriguez-Barradas, K. Breaux, K. Khattak, C.L. Troisi, and M. Velez Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection Clin Infect Dis 33 2001 240 247 Epub 2001 Jun 2015
48. C.S. Graham, L.R. Baden, E. Yu, J.M. Mrus, J. Carnie, and T. Heeren Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis Clin Infect Dis 33 2001 562 569 Epub 2001 Jul 2006
49. S.C. Darby, D.W. Ewart, P.L. Giangrande, R.J. Spooner, C.R. Rizza, and G.M. Dusheiko Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation Lancet 350 1997 1425 1431
50. M.E. Eyster, M.W. Fried, A.M. Di Bisceglie, and J.J. Goedert Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter hemophilia cohort study Blood 84 1994 1020 1023
51. M.E. Eyster, L.S. Diamondstone, J.M. Lien, W.C. Ehmann, S. Quan, and J.J. Goedert Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The multicenter hemophilia cohort study J Acquir Immune Defic Syndr 6 1993 602 610
52. O. Lesens, M. Deschenes, M. Steben, G. Belanger, and C.M. Tsoukas Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection J Infect Dis 179 1999 1254 1258
53. M.V. Ragni, and S.H. Belle Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection J Infect Dis 183 2001 1112 1115 Epub 2001 Mar 1101
54. B. Soto, A. Sanchez-Quijano, L. Rodrigo, J.A. del Olmo, M. Garcia-Bengoechea, and J. Hernandez-Quero Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis J Hepatol 26 1997 1 5
55. J. Garcia-Samaniego, M. Rodriguez, J. Berenguer, R. Rodriguez-Rosado, J. Carbo, and V. Asensi Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C Am J Gastroenterol 96 2001 179 183
56. G. Fattovich, T. Stroffolini, I. Zagni, and F. Donato Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 2004 S35 S50
57. M. Puoti, M. Bonacini, A. Spinetti, V. Putzolu, S. Govindarajan, and S. Zaltron Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus J Infect Dis 183 2001 134 137 Epub 2000 Nov 2016
58. M.S. Sulkowski, and D.L. Thomas Hepatitis C in the HIV-Infected Person Ann Intern Med 138 2003 197 207
59. N. Qurishi, C. Kreuzberg, G. Luchters, W. Effenberger, B. Kupfer, and T. Sauerbruch Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
60. M.S. Sulkowski, R.D. Moore, S.H. Mehta, R.E. Chaisson, and D.L. Thomas Hepatitis C and progression of HIV disease J Am Med Assoc 288 2002 199 206
61. S.H. Mehta, D.L. Thomas, M. Torbenson, S. Brinkley, L. Mirel, and R.E. Chaisson The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection Hepatology 41 2005 123 131
62. G. Greub, B. Ledergerber, M. Battegay, P. Grob, L. Perrin, and H. Furrer Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV cohort study Lancet 356 2000 1800 1805
63. J.K. Rockstroh, and U. Spengler HIV and hepatitis C virus co-infection Lancet Infect Dis 4 2004 437 444
64. T. Laskus, M. Radkowski, A. Piasek, M. Nowicki, A. Horban, and J. Cianciara Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes J Infect Dis 181 2000 442 448
65. K.E. Sherman, J. O'Brien, A.G. Gutierrez, S. Harrison, M. Urdea, and P. Neuwald Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections J Clin Microbiol 31 1993 2679 2682
66. G.M. Lauer, T.N. Nguyen, C.L. Day, G.K. Robbins, T. Flynn, and K. McGowan Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses J Virol 76 2002 2817 2826
67. A.Y. Kim, G.M. Lauer, K. Ouchi, M.M. Addo, M. Lucas, and J. Schulze Zur Wiesch The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T cell count in HIV-1 coinfected individuals Blood 30 2004 30
68. C.S. Graham, M. Curry, Q. He, N. Afdhal, D. Nunes, and C. Fleming Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV Hepatology 40 2004 125 132
69. D.D. Anthony, N.L. Yonkers, A.B. Post, R. Asaad, F.P. Heinzel, and M.M. Lederman Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection J Immunol 172 2004 4907 4916
70. R.P. Woitas, J.K. Rockstroh, I. Beier, G. Jung, B. Kochan, and B. Matz Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients Aids 13 1999 1313 1322
71. S.H. Mehta, A. Cox, D.R. Hoover, X.H. Wang, Q. Mao, and S. Ray Protection against persistence of hepatitis C Lancet 359 2002 1478 1483
72. S.A. Villano, D. Vlahov, K.E. Nelson, S. Cohn, and D.L. Thomas Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection Hepatology 29 1999 908 914
73. M. Bouvier-Alias, K. Patel, H. Dahari, S. Beaucourt, P. Larderie, and L. Blatt Clinical utility of total core antigen quantification: a new indirect marker of HCV replication Hepatology 36 2002 211 218
74. S. Vento, T. Garofano, C. Renzini, F. Cainelli, F. Casali, and G. Ghironzi Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C N Engl J Med 338 1998 286 290
75. T. Poynard, P. Marcellin, S.S. Lee, C. Niederau, G.S. Minuk, and G. Ideo Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 352 1998 1426 1432
76. S. Mauss, H. Klinker, A. Ulmer, R. Willers, B. Weissbrich, and H. Albrecht Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count Infection 26 1998 16 19
77. V. Soriano, J. Garcia-Samaniego, R. Bravo, J. Gonzalez, A. Castro, and J. Castilla Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group Clin Infect Dis 23 1996 585 591
78. R.K. Sterling, and M.S. Sulkowski Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection Semin Liver Dis 24 2004 61 68
79. N. Brau, M. Rodriguez-Torres, D. Prokupek, M. Bonacini, C.A. Giffen, and J.J. Smith Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin Hepatology 39 2004 989 998
80. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-Garcia, and A. Lazzarin Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
81. R.T. Chung, J. Andersen, P. Volberding, G.K. Robbins, T. Liu, and K.E. Sherman Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
82. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, and A. Benzekri Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial J Am Med Assoc 292 2004 2839 2848
83. M. Laguno, J. Murillas, J.L. Blanco, E. Martinez, R. Miquel, and J.M. Sanchez-Tapias Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients Aids 18 2004 F27 F36
84. J.M. Pawlotsky Treating hepatitis C in "difficult-to-treat" patients N Engl J Med 351 2004 422 423
85. S. Norris, C. Taylor, P. Muiesan, B.C. Portmann, A.S. Knisely, and M. Bowles Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection Liver Transpl 10 2004 1271 1278